Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement

Health Technology Assessment

Volumn 12, Issue 35, 2008, Pages

  Lourenco, T ^a   Armstrong, N ^b   N'Dow, J ^c   Nabi, G ^c   Deverill, M ^b   Pickard, R ^b   Vale, L ^a   MacLennan, G ^a   Fraser, C ^a   McClinton, S ^c   Wong, S ^a   Coutts, A ^a   Mowatt, G ^a   Grant, A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HOLMIUM;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; EPIDEMIOLOGICAL DATA; HEALTH CARE ORGANIZATION; HOLMIUM LASER; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; LASER COAGULATION; MALE; MINIMALLY INVASIVE PROCEDURE; POSTOPERATIVE HEMORRHAGE; PROSTATE HYPERTROPHY; PROSTATIC STENT; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REOPERATION; REVIEW; SYSTEMATIC REVIEW; TRANSURETHRAL ELECTROVAPORIZATION; TRANSURETHRAL INCISION OF THE PROSTATE; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TRANSURETHRAL NEEDLE ABLATION; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE; AGED; BIBLIOGRAPHIC DATABASE; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST BENEFIT ANALYSIS; ECHOGRAPHY; ECONOMICS; HYPERTHERMIC THERAPY; LOW LEVEL LASER THERAPY; META ANALYSIS; METHODOLOGY; MINIMALLY INVASIVE SURGERY; PATHOPHYSIOLOGY; SOLID STATE LASER;

AGED; COST-BENEFIT ANALYSIS; DATABASES, BIBLIOGRAPHIC; HUMANS; HYPERTHERMIA, INDUCED; LASER THERAPY; LASERS, SOLID-STATE; MALE; PROSTATIC HYPERPLASIA; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 64949092911     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta12350     Document Type: Review

References (289)

1. Homma Y. Pressure-flow studies in benign prostatic hyperplasia: to do or not to do for the patient? BJU Int 2001;87:19-23.
2. Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992;148:1549-57.
3. Boyle P, Robertson C, Mazzetta C, Keech M, Hobbs FD, Fourcade R, et al. The prevalence of lower urinary tractsymptoms in men and women in four centres. The UrEpik study. BJU Int 2003;92:409-14.
4. Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int 2006;97:3-6.
5. Fong YK, Milani S, Djavan B. Natural history and clinical predictors of clinical progression in benign prostatic hyperplasia. Curr Opin Urol 2005;15:35-8.
6. Wasson JH, Reda DJ, Bruskewitz RC, Elinson J, Keller AM, Henderson WG. A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate. N Engl J Med 1995;332:75-9.
7. Jacobsen SJ, Girman CJ, Lieber MM. Natural history of benign prostatic hyperplasia. Urology 2001;58:5-16.
8. Sarma AV, Jacobsen SJ, Girman CJ, Jacobson DJ, Roberts RO, Rhodes T, et al. Concomitant longitudinal changes in frequency of and bother from lower urinary tract symptoms in community dwelling men. J Urol 2002;168:1446-52.
9. Roberts RO, Jacobsen SJ, Jacobson DJ, Rhodes T, Girman CJ, Lieber MM. Longitudinal changes in peak urinary flow rates in a community based cohort. J Urol 2000;163:107-13.
10. Jacobsen SJ, Jacobson DJ, Girman CJ, Roberts RO, Rhodes T, Guess HA, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol 1997;158:481-7.
11. Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984;132:474-9.
12. Guess HA. Epidemiology and natural history of benign prostatic hyperplasia. Urol Clin North Am 1995;22:247-61.
13. Wei JT, Calhoun EA, Jacobsen SJ. Benign prostatic hyperplasia. In Litwin MS, Saigal CS, editors. Urologic diseases in America. Washington DC National Institutes for Health, National Institute of Diabetes and Digestive and Kidney Diseases: US Government Publishing Office; 2004.
14. McConnell JD, Bruskewitz R, Walsh P, Andriole G, Lieber M, Holtgrewe HL, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group. N Engl J Med 1998;338:557-63.
15. United Nations. World population prospects: the 2004 revision population database. New York: Population Division of the Department of Economic & Social Affairs ofthe United Nations Secretariat; 2004. URL: http://esa.un.org/unpp. Accessed August 2006.
16. Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 1993;150:85-9.
17. Emberton M, Andriole GL, de la RJ, Djavan B, Hoefner K, Vela NR, et al. Benign prostatic hyperplasia: a progressive disease of aging men. Urology 2003;61:267-73.
18. Foley CL, Taylor C, Kirby RS. Counting the cost of treating benign prostatic hyperplasia. BJU Int 2004;93:250-2.
19. McConnell JD, Roehrborn CG, Bautista OM, Andriole GL, Jr, Dixon CM, Kusek JW, et al. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003;349:2387-98.
20. Barry MJ, Fowler FJ, Jr, Mulley AG, Jr, Henderson JV Jr, Wennberg JE. Patient reactions to a program designed to facilitate patient participation in treatment decisions for benign prostatic hyperplasia. Med Care 1995;33:771-82.
21. AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170:530-47.
22. NHS Health and Social Care Information Centre. Hospital episode statistics, 2006. URL: www.hesonline.nhs.uk. Accessed August 2006.
23. Office for National Statistics. United Kingdom Census 2001. URL: www.statistics.gov.uk/census/. Accessed August 2006.
24. de la Rosette JJ, Alivizatos G, Madersbacher S, Rioja Sanz C, Nordling J, Emberton M, for the European Association of Urology. Guidelines on benign prostatic hyperplasia. URL: www.uroweb.nl/files/ uploaded_files/guidelines/11%20BPH.pdf. Accessed March 2006.
25. Naspro R, Salonia A, Colombo R, Cestari A, Guazzoni G, Rigatti P, et al. Update of the minimally invasive therapies for benign prostatic hyperplasia. Curr Opin Urol 2005;51:49-53.
26. Rubenstein J, McVary KT. Transurethral microwave thermotherapy of the prostate (TUMT). Emedicine, 2005. URL: www.emedicine.com/med/ topic3070.htm. Accessed March 2006.
27. Boyle P, Robertson C, Vaughan ED, Fitzpatrick JM. A meta-analysis of trials of transurethral needle ablation for treating symptomatic benign prostatic hyperplasia. BJU Int 2004;94:83-8.
28. Heaton JP. Radiofrequency thermal ablation of the prostate: the TUNA technique. Tech Urol 1995;1:3-10.
29. Muruve NA, Steinbecker K, Willard TB. Transurethral needle ablation of the prostate (TUNA). Emedicine, 2005. URL: www.emedicine.com/med/ topic3069.htm. Accessed March 2006.
30. Ogiste JS, Cooper K, Kaplan SA. Are stents still a useful therapy for benign prostatic hyperplasia? Curr Opin Urol 2003;13:51-7.
31. Madersbacher S, Marberger M. High-energy shockwaves and extracorporeal high-intensity focused ultrasound. J Endourol 2003; 17:667-72.
32. Sullivan LD, McLoughlin MG, Goldenberg LG, Gleave ME, Marich KW. Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophy. Br J Urol 1997;79:172-6.
33. Gelczer RK, Charboneau JW, Hussain S, Brown DL. Complications of percutaneous ethanol ablation. J Ultrasound Med 1998; 17:531-3.
34. Chiang PH, Chuang YC, Huang CC, Chiang CP, Pilot study of transperineal injection of dehydrated ethanol in the treatment of prostatic obstruction. Urology 2003;61:797-801.
35. Levy DA, Cromeens DM, Evans R, Stephens LC, von Eschenbach AC, Pisters LL. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology 1999;53:1245-51.
36. Mutaguchi K, Matsubara A, Kajiwara M, Hanada M, Mizoguchi H, Ohara S, et al. Transurethral ethanol injection for prostatic obstruction: an excellent treatment strategy for persistent urinary retention. Urology 2006;68:307-11.
37. Goya N, Ishikawa N, Ito F, Kobayashi C, Tomizawa Y, Toma H. Transurethral ethanol injection therapy for prostatic hyperplasia: 3-year results. J Urol 2004;172:1017-20.
38. Muschter R. Conductive heat: hot water-induced thermotherapy for ablation of prostatic tissue. J Endourol 2003;17:609-16.
39. Muschter R, Schorsch I, Danielli L, Russel C, Timoney A, Yachia D, et al. Transurethral water-induced thermotherapy for the treatment of benign prostatic hyperplasia: a prospective multicenter clinical trial. J Urol 2000;164:9.
40. Brosman SA. Interstitial laser coagulation of the prostate. Emedicine, 2006. URL: www.emedicine.com/med/topic3033.htm. Accessed August 2006.
41. Prostate management. Medcompare. The buyer's guide for medical professionals, 2006. URL: www.medcompare.com/. Accessed June 2006.
42. Emberton M, Neal DE, Black N, Harrison M, Fordham M, McBrien MP, et al. The National Prostatectomy Audit: the clinical management of patients during hospital admission. Br J Urol 1995; 75:301-16.
43. Reich O, Gratzke C, Stief CG. Techniques and long-term results of surgical procedures for BPH. Eur Urol 2006;49:970-8.
44. Lynch M, Anson K. Time to rebrand transurethral resection of the prostate? Curr Opin Urol 2006;16:20-4.
45. NHS reference costs. NHS trusts elective in-patient HRG data. London: UK Department of Health; 2005. URL: www.dh.gov.uk/ PolicyAndGuidance/OrganisationPolicy/FinanceAndPlanning/ NHSReferenceCosts/fs/en. Accessed August 2006.
46. Riehmann M, Bruskewitz R. Transurethral incision of the prostate and bladder neck. J Androl 1991;12:415-22.
47. Yang Q, Peters TJ, Donovan JL, Wilt TJ, Abrams P. Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: a systematic review and meta-analysis of randomized controlled trials. J Urol 2001;165:1526-32.
48. Kaplan SA, Te AE. Transurethral electrovaporization of the prostate: a novel method for treating men with benign prostatic hyperplasia. Urology 1995;45:566-72.
49. Wilson LC, Gilling PJ. From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nat Clin Pract Urol 2005;2:443-8.
50. Daughtry JD, Rodan BA. Transurethral laser prostatectomy: a comparison of contact tip mode and lateral firing free beam mode. J Clin Laser Med Surg 1993;11:21-8.
51. Kuntz RM. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH). Eur Urol 2006;49:961-9.
52. Te AE. The development of laser prostatectomy. BJU Int 2004; 93:262-5.
53. Gilling PJ, Fraundorfer MR. Holmium laser prostatectomy: a technique in evolution. Curr Opin Urol 1998;8:11-15.
54. Sandhu JS, Ng C, Vanderbrink BA, Egan C, Kaplan SA, Te AE. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004;64:1155-9.
55. Kaplan SA, Laor E, Fatal M, Te AE. Transurethral resection of the prostate versus transurethral electrovaporization of the prostate: a blinded, prospective comparative study with 1-year followup. J Urol 1998;159:454-8.
56. Tewari A, Narayan P. Electrovaporization of the prostate. Br J Urol 1996;78:667-76.
57. Fowler C, McAllister W, Plail R, Karim O, Yang Q. Randomised evaluation of alternative electrosurgical modalities to treat bladder outflow obstruction in men with benign prostatic hyperplasia. Health Technol Assess 2005;9:1-30.
58. Botto H, Lebret T, Barre P, Orsoni JL, Herve JM, Lugagne PM. Electrovaporization of the prostate with the Gyrus device. J Endourol 2001;15:313-16.
59. Smith D, Khoubehi B, Patel A. Bipolar electrosurgery for benign prostatic hyperplasia: transurethral electrovaporization and resection of the prostate. Curr Opin Urol 2005;15:95-100.
60. Sandhu JS, Ng AS, Gonzalez RR, Kaplan SA, Te AE. Photoselective laser vaporization prostatectomy in men receiving anticoagulants. J Endourol 2005;19:1196-8.
61. Kuo RL, Paterson RF, Kim SC, Siqueira TM, Jr, Elhilali MM, Lingeman JE. Holmium laser enucleation of the prostate (HoLEP): a technical update. World J Surg Oncol 2003;1:6.
62. Aho TF, Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR, Frampton CM. Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: a randomized trial. J Urol 2005;174:210-14.
63. Gilling PJ, Kennett KM, Fraundorfer MR. Holmium laser resection v transurethral resection of the prostate: results of a randomized trial with 2 years of follow-up. J Endourol 2000;14:757-60.
64. Kuntz RM, Ahyai S, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate versus transurethral electrocautery resection of the prostate: a randomized prospective trial in 200 patients. J Urol 2004;172:1012-16.
65. de Sio M, Autorino R, Quarto G, Damiano R, Perdona S, di Lorenzo G, et al. Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial. Urology 2006;67:69-72.
66. Eaton AC, Francis RN. The provision of transurethral prostatectomy on a day-case basis using bipolar plasma kinetic technology. BJU Int 2002;89:534-7.
67. Starkman JS, Santucci RA. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int 2005; 95:69-71.
68. Talic RF, El Tiraifi A, El Faqih SR, Hassan SH, Attassi RA, Abdel-Halim RE. Prospective randomized study of transurethral vaporization resection of the prostate using the thick loop and standard transurethral prostatectomy. Urology 2000;55:886-90.
69. Gilling PJ, Mackey M, Cresswell M, Kennett K, Kabalin JN, Fraundorfer MR. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow-up. J Urol 1999; 162:1640-4.
70. Hon NHY, Brathwaite D, Hussain Z, Ghiblawi S, Brace H, Hayne D, et al. A prospective, randomized trial comparing conventional transurethral prostate resection with plasmakinetic vaporization of the prostate: physiological changes, early complications and long-term follow-up. J Urol 2006;176:205-9.
71. Kuntz RM, Lehrich K. Transurethral holmium laser enucleation versus transvesical open enucleation for prostate adenoma greater than 100 gm: a randomized prospective trial of 120 patients. J Urol 2002; 168:1465-9.
72. Kabalin N, Gilling PJ, Fraundorfer MR. Application of the holmium:YAG laser for prostatectomy. J Clin Laser Med Surg 1998; 16:21-7.
73. MacDonald D, McNicholas TA. Drug treatments for lower urinary tract symptoms secondary to bladder outflow obstruction: focus on quality of life. Drugs 2003;63:1947-62.
74. DiSantostefano RL, Biddle AK, Lavelle JP. The long-term cost-effectiveness of treatments for benign prostatic hyperplasia. Pharmacoeconomics 2006;24:171-91.
75. Drummond MF, Sculpher M, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press; 1997.
76. Briggs A. Handling uncertainty in economic evaluations and presenting the results. In McGuire DM, McGuire A, editors. Economic evaluation in health care: merging theory with practice. Oxford: Oxford University Press; 2001. p. 172-214.
77. Ades AE, Lu G, Claxton K. Expected value of sample information calculations in medical decision modeling. Med Decis Making 2004;24:207-27.
78. Ackerman SJ, Rein AL, Blute M, Beusterien K, Sullivan EM, Tanio CP, et al. Cost-effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: I: Methods. Urology 2000; 56:972-80.
79. Blute M, Ackerman SJ, Rein AL, Beusterien K, Sullivan EM, Tanio CP, et al. Cost-effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: IL: Results. Urology 2000; 56:981-7.
80. Manyak MJ, Ackerman SJ, Blute ML, Rein AL, Buesterien K, Sullivan EM, et al. Cost-effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy. J Endourol 2002;16:51-6.
81. DiSantostefano RL, Biddle AK, Lavelle JP. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia. BJU Int 2006;97:1007-16.
82. Howard K, Wortley S. Transurethral needle ablation (TUNA) for the treatment of benign prostatic hyperplasia. MSAC application 1014. Medical Services Advisory Committee, 2002. URL: www.msac.gov.au/internet/ msac/publishing.nsf/Content/1014-1. Accessed July 2005.
83. Briggs A, Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics 1998;13:397-409.
84. Agency for Health Care Policy and Research. Benign prostatic hyperplasia: diagnosis and treatment. Clinical Practice Guideline No. 8. Agency for Health Care Policy and Research, 1994. URL: www.ncbi.nlm.nih.gov/books/bv.fcgi?rid.=hstat6.chapter.17571. Accessed August 2005.
85. American Urological Association. Guideline on the management of benign prostatic hyperplasia (BPH). American Urological Association, 2003. URL: www.auanet.org/guidelines/bph.cfm. Accessed August 2005.
86. Francisca EA, d'Ancona FC, Meuleman EJ, Debruyne FM, de la Rosette JJ. Sexual function following high energy microwave thermotherapy: results of a randomized controlled study comparing transurethral microwave thermotherapy to transurethral prostatic resection. J Urol 1999; 161:486-90.
87. Madersbacher S, Lackner J, Brossner C, Rohlich M, Stancik I, Willinger M, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nationwide, long-term analysis of 23,123 cases. Eur Urol 2005;47:499-504.
88. NHS Centre for Reviews and Dissemination. Undertaking systematic reviews of research on effectiveness. CRD's guidance for those carrying out or commissioning reviews. CRD Report No 4. University of York: Centre for Reviews and Dissemination; 2001.
89. Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998;51:1235-41.
90. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Comniunity Health 1998;52:377-84.
91. Chapple CR, Rosario DJ, Wasserfallen M, Woo HH. A randomised study of the urolume stent vs prostatic surgery. J Urol 1995; 153:436A.
92. Gilling PJ, Kennett K, Aho T, Westenberg A, Fraundorfer M. Holmium bladder neck incision vs holmium laser enucleation of the prostate (HOLEP) as outpatient clinic procedures for small prostate glands (< 40 g): a randomised trial with one year follow-up. J Urol 2004; 171:410.
93. Ho H, Tatt K, Cheng C. A prospective randomized controlled trial comparing bipolar transurethral resection in saline (TURIS) system and conventional monopolar transurethral resection of prostate in men with benign prostate hyperplasia: a 1 year's clinical efficacy and safety. J Endourol 2005;19:A47.
94. Chiou RK, Binard JE, Ebersole ME, Horan JJ, Chiou YK, Lynch B. Randomized comparison of balloon dilation and transurethral incision for treatment of symptomatic benign prostatic hyperplasia. J Endourol 1994;8:221-4.
95. D'Addessi A, Porreca A, Foschi N, Racioppi M. Thick loop prostatectomy in the endoscopic treatment of benign prostatic hyperplasia: results of a prospective randomised study. Urol Int 2005;74:114-17.
96. Holmes M, Cox J, Stewart J, King D, Bary P, Wright W. Thick vs thin loop transurethral resection of the prostate: a double-blind prospective trial of early morbidity. BJU Int 2002;89:197-201.
97. Leskinen MJ, Kilponen A, Lukkarinen O, Tammela TL. Transurethral needle ablation for the treatment of chronic pelvic pain syndrome (category III prostatitis): a randomized, sham-controlled study. Urology 2002; 60:300-4.
98. Talic RF, El Tiraifi A, El Faqih SR, Abdel-Halim RE. A prospective randomized study of the thick loop and standard wire-loop in transurethral prostatectomy: one year follow up. J Endourol 2000;14:A36.
99. Tsukada O, Murakami M, Kosuge T, Yokoyama H. Treatment of benign prostatic hyperplasia using transurethral microwave thermotherapy and dilatation with double-balloon catheter. J Endourol 2005; 19:1016-20.
100. Yeni E, Unal D, Verit A, Gulum M. Minimal transurethral prostatectomy plus bladder neck incision versus standard transurethral prostatectomy in patients with benign prostatic hyperplasia: a randomised prospective study. Urol Int 2002;69:283-6.
101. Hansen BJ, Flyger H, Mortensen S, Mensink HJ, Meyhoff HH. Symptomatic outcome of transurethral prostatectomy, alpha-blockade and placebo in the treatment of benign prostatic hyperplasia. Evaluation of treatment with the Danish Prostatic Symptom Score (DAN-PSS-1) system. The ALFECH Study Group. Scand J Urol Nephrol 1996;30:103-7.
102. Petas A, Isotalo T, Talja M, Tammela TL, Valimaa T, Tormala P. A randomised study to evaluate the efficacy of a biodegradable stent in the prevention or postoperative urinary retention after interstitial laser coagulation of the prostate. Scand J Urol Nephrol 2000; 34:262-6.
103. Roehrborn CG, Rhee EY, Miller SD, Brawer MK, Heron SP, Ruckle HC, et al. Initial results of a randomized multi-center trial comparing the efficacy and safety of Indigo Optima laser treatment with tamsulosin in men with LUTS and BPH. J Urol 2005;173:424.
104. Yamamoto M, Hibi H, Miyake, K. A comparison of transurethral resection of the prostate and medical treatment for the patient with moderate symptoms of benign prostatic hyperplasia. Nagoya J Med Sci 1996; 59:11-16.
105. A comparison of quality of life with patient reported symptoms and objective findings in men with benign prostatic hyperplasia. The Department of Veterans Affairs Cooperative Study of transurethral resection for benign prostatic hyperplasia. J Urol 1993; 150:1696-700.
106. Plante M. A safety comparison of a randomized mutli-centre study evaluating transurethral ethanol ablation of the prostate (TEAP) for the treatment of benign prostatic hyperplasia (BPH). Eur Urol Suppl 2004;3:143.
107. Abbou C-C, Colombel M, Payan C, Viens-Bitker C, Richard F, Boccon L, et al. Transrectal and transurethral hyperthermia versus sham to treat benign prostatic hyperplasia: a double blind, randomized, multicentric study. J Urol 1994;151:418A.
108. Billebaud T, Mechali P, Astier L, Monneins F, Savatovsky I, Coloby P. Transurethral microwave hyperthermia for benign prostatic hyperplasia: is it effective? Results of a multicentric randomized prospective study versus placebo with six month follow-up. J Urol 1994; 151:417A.
109. Brookes S, Peters T, Campbell R, Featherstone K, Neal D, Abrams P, et al. Including a 'no active intervention' arm in surgical trials is possible: evidence from the CLasP randomised trial. J Health Serv Res Policy 2003;8:209-14.
110. Çetinkaya M, Ozturk B, Akdemir O, Aki FT. A comparison of fluid absorption during transurethral resection and transurethral vaporization for benign prostatic hyperplasia. BJU Int 2000;86:820-3.
111. de la Rosette JJ, Floratos DL, Severens JL, Laguna MP, Kiemeney LA, Debruyne FM. Cost-consequences analysis of TUMT compared to TURP. Results of a randomized study. J Urol 2001;165:292.
112. Holtgrewe HL. An American Urological Association prospective, randomized clinical trial in the treatment of benign prostatic hyperplasia. Cancer 1992;70:351-4.
113. Kuntz RM, Lehrich K, Fayad A. Transurethral holmium laser enucleation of the prostate (HoLEP) compared to traditional transurethral resection of theprostate (TURP) for prostates smaller than 100 grams: a randomized prospective clinical study. J Endourol 2001;15:A41.
114. Lawrence WT. Ablation of the prostate by laser (ELAP). Journal d' Urologie 1993;99:351.
115. Norby B, Nielsen HV, Frimodt-Moller PC. Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate. Scand J Urol Nephrol 2002;36:286-95.
116. Patel A, Fuchs GJ, Gutierrez-Aceves J, Ryan TP. A prospectively randomized study of energy utilization during transurethral electrosurgical resection (TURP) and electro-vaporization (TUEVAP). J Endourol 1996;10:S82.
117. Patel A, Fuchs GJ, Gutierrez-Aceves J. A pilot study of energy utilization patterns during different transurethral electrosurgical treatments of the prostate. Urology 1997;50:138-41.
118. Patankar SB, Dobhada SH. Superpulse bipolar prostate resection vs conventional TURP: a randomized prospective trial with 3 months follow-up - and Indian experience. J Endourol 2004;18:A77.
119. Eaton AC, de Silva B, Duncan NH, Francis RN. A randomised prospective study comparing the performance of the 4mm plasma kinetic loop against the standard monopolar TURP in prostates 40-100gm size. J Urol 2004;171:398.
120. Lloyd SN. A multicentre comparative study of the Gyrus plasmakinetic bipolar electrosurgical system and conventional monopolar loop TURP in BPH. BJU Int 2002;90:13.
121. Tuhkanen K, Heino A, Aaltoma S, Ala-Opas M. Sexual function of LUTS patients before and after neodymium laser prostatectomy and transurethral resection of prostate. A prospective, randomized trial. Urol Int 2004;73:137-42.
122. Patel A, Fuchs GJ, Gutierrez-Aceves J, Andrade-Perez F. Completeness and efficiency of prostate tissue removal: loop resection compared with a new operative technique of transurethral electrovaporization. BJU Int 1999;84:43-9.
123. Costello AJ, Crowe HR, Jackson T, Street A. A randomised single institution study comparing laser prostatectomy and transurethral resection of the prostate. Ann Acad Med 1995;24:700-4.
124. Ahmed M, Bell T, Lawrence WF, Ward JP, Watson GM. Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study. Br J Urol 1997;79:181-5.
125. Bdesha AS, Bunce CJ, Snell ME, Witherow RO. Sham controlled trial of transurethral microwave therapy with subsequent treatment of the control-group. J Urol 1994;152:453-8.
126. Blute ML, Patterson DE, Segura JW, Tomera KM, Hellerstein DK. Transurethral microwave thermotherapy v sham treatment: double-blind randomized study. J Endourol 1996;10:565-73.
127. Carter A, Sells H, Speakman M, Ewings P, MacDonagh R, O'Boyle P. A prospective randomized controlled trial of hybrid laser treatment or transurethral resection of the prostate, with a 1-year follow-up. BJU Int 1999;83:254-9.
128. Erdaǧi U, Akman RY, Sargin SY, Yazicioglu A. Transurethral electrovaporization of the prostate versus transurethral resection of the prostate: a prospective randomized study. Arch Ital Urol Androl 1999;71:125-30.
129. Hammadeh MY, Madaan S, Hines J, Philp T. 5-year outcome of a prospective randomized trial to compare transurethral electrovaporization of the prostate and standard transurethral resection. Urology 2003; 61:1166-71.
130. Kursh ED, Concepcion R, Chan S, Hudson P, Ratner M, Eyre R. Interstitial laser coagulation versus transurethral prostate resection for treating benign prostatic obstruction: a randomized trial with 2-year follow-up. Urology 2003;61:573-8.
131. Liedberg F, Adell L, Hagberg G, Palmqvist IB. Interstitial laser coagulation versus transurethral resection of the prostate for benign prostatic enlargement - a prospective randomized study. Scand J Urol Nephrol 2003;37:494-7.
132. Liu CK, Lee WK, Ko MC, Chiang HS, Wan KS. Transurethral electrovapor resection versus standard transurethral resection treatment for a large prostate: a 2-year follow-up study conducted in Taiwan. Urol Int 2006;76:144-9.
133. Ogden C, Reddy P, Johnson H, Carter S. Sham vs TUMT: a randomized study with cross over. J Urol 1993;149(Suppl 4):250A.
134. Wilson LC, Gilling P, Williams A, Kennett KM, Frampton CM, Westenberg AM, et al. A randomised trial comparing holmium laser enucleation versus transurethral resection in the treatment of prostates larger than 40 grams: results at 2 years. Eur Urol 2006;50:569-73.
135. Christensen MM, Aagaard J, Madsen PO. Transurethral resection versus transurethral incision of the prostate. A prospective randomized study. Urol Clin North Am 1990;17:621-30.
136. Donovan JL, Peters TJ, Neal DE, Brookes ST, Gujral S, Chacko KN, et al. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: the CLasP study. J Urol 2000;164:65-70.
137. Dunsmuir WD, McFarlane J P, Tan A, Dowling C, Downie J, Kourambas J, et al. Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up. Prostate Cancer Prostatic Dis 2003; 6:182-6.
138. Gallucci M, Puppo P, Perachino M, Fortunato P, Muto G, Breda G, et al. Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients. Eur Urol 1998;33:359-64.
139. Gujral S, Abrams P, Donovan JL, Neal DE, Brookes ST, Chacko KN, et al. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: the CLasP study. J Urol 2000;164:59-64.
140. Patel A, Fuchs GJ, Gutierrez-Aceves J, Ryan TP. Prostate heating patterns comparing electrosurgical transurethral resection and vaporization: a prospective randomized study. J Urol 1997; 157:169-72.
141. Bouchier-Hayes DM, Anderson P, Van Appledorn S, Bugeja P, Costello AJ. KTP laser versus transurethral resection: early results of a randomized trial. J Endourol 2006;20:580-5.
142. Ekengren J, Haendler L, Hahn RG. Clinical outcome 1 year after transurethral vaporization and resection of the prostate. Urology 2000;55:231-5.
143. Abbou C-C, Payan C, Viens-Bitker C, Richard F, Boccon-Gibod L, Jardin A, et al. Transrectal and transurethral hyperthermia versus sham treatment in benign prostatic, hyperplasia: a double-blind randomized multicentre clinical trial. Br J Urol 1995;76:619-24.
144. Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, et al. Transurethral needle ablation versus transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia: 5-year results of a prospective, randomized, multicenter clinical trial. J Urol 2004;171:2336-40.
145. McAllister WJ, Absalom MJ, Mir K, Shivde S, Anson K, Kirby RS, et al. Does endoscopic laser ablation of the prostate stand the test of time? Five-year results from a multicentre randomized controlled trial of endoscopic laser ablation against transurethral resection of the prostate. BJU Int 2000;85:437-9.
146. Shingleton WB, Farabaugh P, May W. Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 2002;60:305-8.
147. Singh H, Desai MR, Shrivastav P, Vani K. Bipolar versus monopolar transurethral resection of prostate: randomized controlled study. J Endourol 2005;19:333-8.
148. Zorn BH, Bauer JJ, Ruiz HE, Thrasher JB. Randomized trial of safety and efficacy of transurethral resection of the prostate using contact laser versus electrocautery. Tech Urol 1999;5:198-201.
149. Rodrigo Aliaga M, Valls Blasco F, Jimenez Cruz JF. Lasers as an alternative to the endoscopic surgery in BPH. Actas Urol Esp 1998;22:17-22.
150. Kim JY, Moon KH, Yoon CJ, Park TC. Bipolar transurethral resection of the prostate: a comparative study with monopolar transurethral resection. Korean J Urol 2006;47:493-7.
151. Kim TS, Choi S, Rhew HY, Ahn JH, Jang JH, Cho MH. Comparative study on the treatment outcome and safety of TURP, ILC, TUNA and TEAP for patients with benign prostatic hyperplasia. Korean J Urol 2006; 47:13-19.
152. Riehmann M, Knes JM, Heisey D, Madsen PO, Bruskewitz RC. Transurethral resection versus incision of the prostate: a randomized, prospective study. Urology 1995;45:768-75.
153. Tuhkanen K, Heino A, Aaltomaa S, Ala-Opas M. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged priostates. Scand J Urol Nephrol 2003;37:487-93.
154. Chacko KN, Donovan JL, Abrams P, Peters TJ, Brookes ST, Thorpe AC, et al. Transurethral prostatic resection or laser therapy for men with acute urinary retention: the CLasP randomized trial. J Urol 2001;166:166-70.
155. Fung BT, Li SK, Yu CF, Lau BE, Hou SS. Prospective randomized controlled trial comparing plasmakinetic vaporesection and conventional transurethral resection of the prostate. Asian J Surg 2005; 28:24-8.
156. Gotoh M, Okamura K, Hattori R, Nishiyama N, Kobayashi H, Tanaka K, et al. A randomized comparative study of the Bandloop versus the standard loop for transurethral resection of the prostate. J Urol 1999;162:1645-7.
157. Hellström P, Lukkarinen O, Kontturi M. Bladder neck incision or transurethral electroresection for the treatment of urinary obstruction caused by a small benign prostate? A randomized urodynamic study. Scand J Urol Nephrol 1986;20:187-92.
158. Küpeli S, Baltaci S, Soygur T, Aytac S, Yilmaz E, Budak M. A prospective randomized study of transurethral resection of the prostate and transurethral vaporization of the prostate as a therapeutic alternative in the management of men with BPH. Eur Urol 1998; 34:15-18.
159. Larson TR, Blute ML, Bruskewitz RC, Mayer RD, Ugarte RR, Utz WJ. A high-efficiency microwave thermoablation system for the treatment of benign prostatic hyperplasia: results of a randomized, sham-controlled, prospective, double-blind, multicenter clinical trial. Urology 1998;51:731-42.
160. Nawrocki JD, Bell TJ, Lawrence WT, Ward JP. A randomized controlled trial of transurethral microwave thermotherapy. Br J Urol 1997; 79:389-93.
161. Seckiner I, Yesilli C, Akduman B, Altan K, Mungan NA. A prospective randomized study for comparing bipolar plasmakinetic resection of the prostate with standard TURP. Urol Int 2006;76:139-43.
162. Nathan MS, Wickham JEA. TVP: a cheaper and effective alternative to TURP. Minim Invasive Ther Allied Technol 1996;5:292-6.
163. Cowles RS, III, Kabalin JN, Childs S, Lepor H, Dixon C, Stein B, et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology 1995;46:155-60.
164. Keoghane SR, Lawrence KC, Gray AM, Doll HA, Hancock AM, Turner K, et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int 2000; 85:74-8.
165. Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, et al. Feedback microwave thermotherapy versus TURP for clinical BPH - a randomized controlled multicenter study. Urology 2002; 60:292-9.
166. d'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, de la Rosette JJ. Transurethral resection of the prostate vs high-energy thermotherapy of the prostate in patients with benign prostatic hyperplasia: long-term results. Br J Urol 1998;81:259-64.
167. Dahlstrand C, Geirsson G, Fall M, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: preliminary results of a randomized study. Eur Urol 1993;23:292-8.
168. Dahlstrand C, Walden M, Geirsson G, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for symptomatic benign prostatic obstruction: a prospective randomized study with a 2-year follow-up. Br J Urol 1995;76:614-8.
169. de la Rosette JJ, Floratos DL, Severens JL, Kiemeney LA, Debruyne FM, Pilar LM. Transurethral resection vs microwave thermotherapy of the prostate: a cost-consequences analysis. BJU Int 2003; 92:713-8.
170. Albala DM, Fulmer BR, Turk TM, Koleski F, Andriole G, Davis BE, et al. Office-based transurethral microwave thermotherapy using the TherMatrx TMx-2000. J Endourol 2002;16:57-61.
171. Brehmer M, Wiksell H, Kinn A. Sham treatment compared with 30 or 60 min of thermotherapy for benign prostatic hyperplasia: a randomized study. BJU Int 1999;84:292-6.
172. de Wildt MJ, Hubregtse M, Ogden C, Carter SS, Debruyne FM, de la Rosette JJ. A 12-month study of the placebo effect in transurethral microwave thermotherapy. BrJ Urol 1996;77:221-7.
173. Trachtenberg J, Roehrborn CG. Updated results of a randomized, double-blind, multicenter sham-controlled trial of microwave thermotherapy with the Dornier Urowave in patients with symptomatic benign prostatic hyperplasia. Urowave Investigators Group. World J Urol 1998;16:102-8.
174. Zerbib M, Steg A, Conquy S, Debre B. Hyperhermia: a randomized prospective study applying hyperthermia or a sham procedure in obstructive benign hyperplasia of the prostate. Prog Clin Biol Res 1994;386:439-48.
175. Cimentepe E, Unsal A, Saglam R. Randomized clinical trial comparing transurethral needle ablation with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: results at 18 months. J Endourol 2003;17:103-7.
176. Hindley RG, Mostafid AH, Brierly RD, Harrison NW, Thomas PJ, Fletcher MS. The 2-year symptomatic and urodynamic results of a prospective randomized trial of interstitial radiofrequency therapy vs transurethral resection of the prostate. BJU Int 2001;88:217-20.
177. Kabalin JN, Gill HS, Bite G, Wolfe V. Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment. J Urol 1995;153:94-7.
178. Mårtenson AC, de la Rosette JJMC. Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode laser system: results of an evolving technology. Prostate Cancer Prostatic Dis 1999;2:148-54.
179. Suvakovic N, Hindmarsh JR. A step towards day case prostatectomy. Br J Urol 1996;77:212-14.
180. Dørflinger T, Jensen FS, Krarup T, Walter S. Transurethral prostatectomy compared with incision of the prostate in the treatment of prostatism caused by small benign prostate glands. Scand J Urol Nephrol 1992;26:333-8.
181. Jahnson S, Dalen M, Gustavsson G, Pedersen J. Transurethral incision versus resection of the prostate for small to medium benign prostatic hyperplasia. Br J Urol 1998;81:276-81.
182. Li MK, Ng AS. Bladder neck resection and transurethral resection of the prostate: a randomized prospective trial. J Urol 1987; 138:807-9.
183. Nielsen HO. Transurethral prostatotomy versus transurethral prostatectomy in benign prostatic hypertrophy. A prospective randomised study. Br J Urol 1988;61:435-8.
184. Saporta L, Aridogan IA, Erlich N, Yachia D. Objective and subjective comparison of transurethral resection, transurethral incision and balloon dilatation of the prostate. A prospective study. Eur Urol 1996;29:439-45.
185. Soonawalla PF, Pardanani DS. Transurethral incision versus transurethral resection of the prostate. A subjective and objective analysis. Br J Urol 1992;70:174-7.
186. Tkocz M, Prajsner A. Comparison of long-term results of transurethral incision of the prostate with transurethral resection of the prostate, in patients with benign prostatic hypertrophy. Neurourol Urodyn 2002;21:112-16.
187. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of > 40 g. BJU Int 2006;97:85-9.
188. Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, et al. Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004;172:1926-9.
189. Westenberg A, Gilling P, Kennett K, Frampton C, Fraundorfer M. Holmium laser resection of the prostate versus transurethral resection of the prostate: results of a randomized trial with 4-year minimum long-term followup. J Urol 2004;172:616-19.
190. Mottet N, Anidjar M, Bourdon O, Louis JF, Teillac P, Costa P, et al. Randomized comparison of transurethral electroresection and holmium: YAG laser vaporization for symptomatic benign prostatic hyperplasia. J Endourol 1999;13:127-30.
191. Tuhkanen K, Heino A, Ala-Opas M. Two-year follow-up results of a prospective randomized trial comparing hybrid laser prostatectomy with TURP in the treatment of big benign prostates. Scand J Urol Nephrol 2001;35:200-4.
192. Sengör F, Kose O, Yucebas E, Beysel M, Erdogan K, Narter F. A comparative study of laser ablation and transurethral electroresection for benign prostatic hyperplasia: results of a 6-month follow-up. Br J Urol 1996;78:398-400.
193. van Melick HH, van Venrooij GE, Boon TA. Long-term follow-up after transurethral resection of the prostate, contact laser prostatectomy, and electrovaporization. Urology 2003;62:1029-34.
194. Nuhoǧlu B, Ayyildiz A, Karaguzel E, Cebeci O, Germiyanoglu C. Plasmakinetic prostate resection in the treatment of benign prostate hyperplasia: results of 1-year follow up. Int J Urol 2006; 13:21-4.
195. Tefekli A, Muslumanoglu AY, Baykal M, Binbay M, Tas A, Altunrende F. A hybrid technique using bipolar energy in transurethral prostate surgery: a prospective, randomized comparison. J Urol 2005; 174:1339-43.
196. Çetinkaya M, Ulusoy E, Adsan O, Saglam H, Ozturk B, Basay S. Comparative early results of transurethral electroresection and transurethral electrovaporization in benign prostatic hyperplasia. Br J Urol 1996; 78:901-3.
197. Küpeli B, Yalcinkaya F, Topaloglu H, Karabacak O, Gunlusoy B, Unal S. Efficiacy of transurethral electrovaporization of the prostate with respect to standard transurethral resection. J Endourol 1998; 12:591-4.
198. Netto NR, Jr, de Lima ML, Lucena R, Lavoura NS, Cortado PL, Netto MR. Is transurethral vaporization a remake of transurethral resection of the prostate? J Endourol 1999;13:591-4.
199. Nuhoǧlu B, Ayyildiz A, Fidan V, Ersoy E, Huri E, Germiyanogu C. Transurethral electrovaporization of the prostate: is it any better than standard transurethral prostatectomy? 5-year follow-up. J Endourol 2005;19:79-82.
200. Shokeir AA, al Sisi H, Farage YM, el Maaboud MA, Saeed M, Mutabagani H. Transurethral prostatectomy: a prospective randomized study of conventional resection and electrovaporization in benign prostatic hyperplasia. Br J Urol 1997;80:570-4.
201. Wang ZL, Wang XF, Li B, Ji JT, Hou SC, Shao SX, et al. Comparative study of transurethral electrovaporization of prostate versus transurethral resection of prostate on benign prostatic hyperplasia. Zhong Hua Van Ke Xue 2002;8:428-30.
202. Helke C, Manseck A, Hakenberg OW, Wirth MP. Is transurethral vaporesection of the prostate better than standard transurethral resection? Eur Urol 2001;39:551-7.
203. Küpeli S, Yilmaz E, Soygur T, Budak M. of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia. J Endourol 2001;15:317-21.
204. Abdel-Khalek M, El Hammady S, Ibrahiem E. A 4-year follow-up of a randomized prospective study comparing transurethral electrovaporization of the prostate with neodymium:YAG laser therapy for treating benign prostatic hyperplasia. BJU Int 2003;91:801-5.
205. Narayan P, Tewari A, Aboseif S, Evans C. A randomized study comparing visual laser ablation and transurethral evaporation of prostate in the management of benign prostatic hyperplasia. J Urol 1995; 154:2083-8.
206. Shingleton WB, Renfroe LD, Kolski JM, Fowler JE, Jr. A randomized prospective study of transurethral electrovaporization vs laser ablation of the prostate in men with benign prostatic hypertrophy. Scand J Urol Nephrol 1998;32:266-9.
207. d'Ancona FC, Francisca EA, Witjes WP, Welling L, Debruyne FM, de la Rosette JJ. High energy thermotherapy versus transurethral resection in the treatment of benign prostatic hyperplasia: results of a prospective randomized study with 1 year of follow-up. J Urol 1997; 158:120-5.
208. Dahlstrand C, Fall M, Geirsson G, Petterson DE. Transurethral microwave thermotherapy versus transurethral resection for benign prostatic hyperplasia: results of a randomized study. J Urol 1993; 149:250A.
209. Dahlstrand C, Geirsson G, Walden M. Prospective randomized study between transurethral resection (TURP) and transurethral microwave treatment (TUMT) for benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1993;151:32-3.
210. Dahlstrand C, Walden M, Geirsson G, Sommar S, Pettersson S. Transurethral microwave thermotherapy versus transurethral resection for BPH. Prog Clin Biol Res 1994;386:455-61.
211. Duelund J, Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, et al. Prostalund feedback treatment versuis TURP: a prospective randomized multicenter study with 36 month follow-up. Scand J Urol Nephrol 2003;37(Suppl214):34-5.
212. Floratos DL, Kiemeney LA, Rossi C, Kortmann BB, Debruyne FM, de la Rosette JJ. Long-term follow-up of randomized transurethral microwave thermotherapy versus transurethral prostatic resection study. J Urol 2001;165:1533-8.
213. Francisca EA, d'Ancona FC, Hendriks JC, Kiemeney LA, Debruyne FM, de la Rosette JJ. A randomized study comparing high-energy TUMT to TURP: quality-of-life results. Eur Urol 2000;38:569-75.
214. Kobelt G, Spangberg A, Mattiasson A. The cost of feedback microwave thermotherapy compared with transurethral resection of the prostate for treating benign prostatic hyperplasia. BJU Int 2004; 93:543-8.
215. Nordling J, Wagrell L, Larson T, Duelund J, Kroyer K, Mattiasson A. ProstaLund feedback treatment (PLFT) vs TURP: a prospective randomized muliticenter study with 36 month follow up. BJU Int 2005; 95(Suppl 5):75.
216. Wagrell L, Schelin S, Nordling J, Larsson T, Mattiasson A. Prostalund microwave feedback treatment compared with TURP for treatment of BPH: a prospective randomized multicentre study. Aust NZJ Surg 2003; 73:A146.
217. Wagrell L, Schelin S, Nordling J, Richthoff J, Magnusson B, Schain M, et al. ProstaLund microwave feedback treatment compared with TURP for treatment of BHP: a prospective randomized multicenter study with 24 months folllow up. J Urol 2003;169(Suppl 4):1748.
218. Walden M, Acosta S, Carlsson P, Pettersson S, Dahlstrand C. A cost-effectiveness analysis of transurethral resection of the prostate and transurethral microwave thermotherapy for treatment of benign prostatic hyperplasia: two-year follow-up. Scand J Urol Nephrol 1998;32:204-10.
219. Albala DM, Koleski F, Nuzzarello J, Davis BE, Eure GR, Andriole G, et al. Periurethral prostatic microwave thermotherapy using the Thermatrx TMX-2000TM: follow-up of a randomized, blinded, sham-controlled study in patients with BPH. J Urol 2000; 163:269.
220. Albala DM, Andriole G, Davies B. Transurethral microwave thermotherapy (TUMT) using the Thermatrx TMX-2000: durability exhibited in a study comparing TUMT with a sham procedure in patients with benign prostatic hyperplasia. Abstract no. 1746. 2003. Annual Meeting of the American Urological Association.
221. Albala DM, Andriole G, Davies B, Eure GR, Kabalin JN, Lingeman JE, et al. Transurethral microwave thermotherapy (TUMT) using the Thermatrx TMX-2000: long-term results in a study comparing TUMT with a sham procedure in patients with benign prostatic hyperplasia. Abstract no. 1551. 2005. Annual Meeting of the American Urological Association.
222. Bdesha AS, Bunce CJ, Kelleher JP, Snell ME, Vukusic J, Witherow OR. Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial. BMJ 1993;306:1293-6.
223. de la Rosette JJ, de Wildt MJ, Alivizatos G, Froeling FM, Debruyne FM. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology 1994;22:58-63.
224. Francisca EA, d'Ancona FC, Hendriks JC, Kiemeney LA, Debruyne FM, de la Rosette JJ. Quality of life assessment in patients treated with lower energy thermotherapy (Progtasoft 2.0): results of a randomized transurethral microwave thermotherapy versus sham study. J Urol 1997;158:1839-44.
225. Kabalin JN, Albala DM, Koleski F, Andriole G, Sundaram C, Davis BE, et al. Office-based transurethral microwave thermotherapy for benign prostatic hyperplasia (BPH) using the TherMatrxTM TMx7-2000TM: results of a multi-center prospective randomized sham-controlled trial. J Urol 2001;165:367-8.
226. Roehrborn C, Sech S, Preminger G, Cohen T, Perlmutter A, Razvi H, et al. A randomized, blinded study comparing microwave thermotherapy (Dornier Urowave) with a sham procedure in patients with clinical benign prostatic hyperplasia (BPH). J Endourol 1997; 11(Suppl1):S155.
227. Roehrborn CG, Preminger G, Newhall P, Denstedt J, Razvi H, Chin LJ, et al. Microwave thermotherapy for benign prostatic hyperplasia with the Dornier Urowave: results of a randomized, double-blind, multicenter, sham-controlled trial. Urology 1998;51:10-28.
228. Tan AH, Nott L, Hardie WR, Chin JL, Denstedt JD, Razvi H. Long-term results of microwave thermotherapy for symptomatic benign prostatic hyperplasia. J Endourol 2005;19:1191-5.
229. Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, et al. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-93.
230. Mostafid AH, Harrison NW, Thomas PJ, Fletcher MS. A prospective randomized trial of interstitial radiofrequency therapy versus transurethral resection for the treatment of benign prostatic hyperplasia. Br J Urol 1997;80:116-22.
231. Naslund M, Oesterling JE, Issa M, Roehrborn CG, Bruskewitz R, Perez-Marrero R, et al. Long term follow-up of a prospective, randomized clinical trial comparing transurethral needle ablation (TUNA) to transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH). J Endourol 1997; 11:S188.
232. Naslund M, Perez-Marrero R, Roehrborn C, Bruskewitz R, Issa M. Intermediate term outcomes of TUNA for BPH: 36 month results of the TUNA vs TURP US randomized study. J Urol 1999;161:389.
233. Roehrborn CG, Burkhard FC, Bruskewitz RC, Issa MM, Perez-Marrero R, Naslund MJ, et al. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study. J Urol 1999; 162:92-7.
234. Anson K, Nawrocki J, Buckley J, Fowler C, Kirby R, Lawrence W, et al. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995;46:305-10.
235. Brookes ST, Donovan JL, Peters TJ, Abrams P, Neal DE. Sexual dysfunction in men after treatment for lower urinary tract symptoms: evidence from randomised controlled trial. BMJ 2002;324:1059-61.
236. Donovan JL, Brookes ST, Kennedy LG, Abrams P, Peters TJ, Neal DE. The CLasP randomised controlled trial: comparing laser therapy, conservative management and TURP for men with lower urinary tract symptoms. J Urol 1998;159:248.
237. Kabalin JN. Laser prostatectomy performed with a right angle firing neodymium:YAG laser fiber at 40 watts power setting. J Urol 1993;150:95-9.
238. Aagaard J, Chopin D, Knes J, Madsen PO. Transurethral resection TURP vs incision TUIP of the prostate: a prospective randomized study. J Urol 1990;143:411A.
239. Riehmann M, Knes J, Madaan S, Bruskewitz R. Transurethral resection (TURP) versus incision (TUIP) of the prostate: A prospective randomized study. J Urol 1993;149(Suppl 4):323A.
240. Sparwasser C, Riehmann M, Knes J, Madsen PO. Long-term results of transurethral prostate incision (TUIP) and transurethral prostate resection (TURP). A prospective randomized study. Urologe (Ausg A) 1995;34:153-7.
241. Briganti A, Naspro R, Vavassori I, Suardi N, Salonia A, Mazzoccoli B, et al. Impact of holmium laser enucleation (HoLEP) versus transurethral resection (TURP) of the prostate on sexual function: results of a prospective multicentric randomized trial. J Urol 2004;171:398.
242. Briganti A, Naspro R, Vavassori I, Suardi N, Salonia A, Mazzoccoli B, et al. Impact of holmium laser enucleation (HoLEP) versus transurethral resection (TURP) of the prostate on sexual function: results of a prospective multicentric randomized trial. Eur Urol Suppl 2004;3:144.
243. Fraundorfer MR, Gilling PJ, Kennett KM, Dunton NG. Holmium laser resection of the prostate is more cost-effective than transurethral resection of the prostate: results of a randomized prospective study. Urology 2001;57:454-8.
244. Gilling P, Westenberg A, Kennett KM, Fraundorfer MR. Holmium laser resection of the prostate (HOLRP) vs transurethral resection of the prostate (TURP): results at 4 years. Aust NZJ Surg 2003; 73:A145.
245. Gilling PJ, Fraundorfer MR, Westenberg AM, Neill MG, Frampton CM, Kennett KM. Relief of bladder outflow obstruction (BOO) following HoLEP and TURP: a pooled analysis of data from 4 randomized trials. BJU Int 2005;95(Suppl5):74.
246. Kuntz RM, Ahyai S, Lehrich K. Holmium laser enucleation vs TURP: a randomized prospective study with 2 years of follow-up. BJU Int 2003;91(Suppl2):71.
247. Montosori F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M. Holmium laser enucleation versus transurethral resection of the prostate: results from a two-centre prospective randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 2004;171:409.
248. Tan AH, Gilling PJ, Kennett KM, Frampton C, Westenberg AM, Fraundorfer MR. A randomized trial comparing holmium laser enucleation of the prostate with transurethral resection of the prostate for the treatment of bladder outlet obstruction secondary to benign prostatic hyperplasia in large glands (40 to 200 grams). J Urol 2003;170:1270-4.
249. Carter A, Sells H, Speakman M, Ewings, P, O'Boyle P, MacDonagh R. Quality of life changes following KTP/Nd:YAG laser-treatment of the prostate and TURP. Eur Urol 1999;36:92-8.
250. Jenkinson C, Gray A, Doll H, Lawrence K, Keoghane S, Layte R. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures. Med Care 1997;35:1109-18.
251. Keoghane S, Cranston D, Lawrence K, Doll H. The Oxford laser prostate trial: a prospective randomised controlled trial of contact vaporisation of the prostate versus TURP. J Urol 1995;153:230A.
252. Keoghane SR, Doll HA, Lawrence KC, Jenkinson CP, Cranston DW. The Oxford Laser Prostate Trial: sexual function data from a randomized controlled clinical trial of contact laser prostatectomy. Eur Urol 1996; 30:424-8.
253. Keoghane SR, Lawrence KC, Jenkinson CP, Doll HA, Chappel DB, Cranston DW. The Oxford Laser Prostate Trial: sensitivity to change of three measures of outcome. Urology 1996;47:43-7.
254. Keoghane SR, Cranston DW, Lawrence KC, Doll HA, Fellows GJ, Smith JC. The Oxford Laser Prostate Trial: a double-blind randomized controlled trial of contact vaporization of the prostate against transurethral-resection; preliminary results. Br J Urol 1996; 77:382-5.
255. Keoghane SR, Sullivan ME, Doll HA, Kourambas J, Cranston DW. Five-year data from the Oxford Laser Prostatectomy Trial. BJU Int 2000; 86:227-8.
256. Mottet N, Anidjar M, Costa P, Louis JF, Teillac P, Duc A. A randomized study comparing the holmium-YAG vaporisation and the transurethral resection of symptomatic BPH. J Endourol l997; 11(Suppl1):Sl60.
257. Pearcy R, Carter A, Sells H, O'Boyle P, MacDonagh R, Speakman M, et al. Long term follow up of hybrid KlTP/ND:YAG laser treatment of the prostate versus TURP: a prospective randomised trial, 18 month results. J Urol 1999;161:390.
258. Shingleton WB, Terrell F, Renfroe DL, Kolski JM, Fowler JE Jr. A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia. Urology 1999;54:1017-21.
259. Shingleton WB, Farabaugh P. Prospective randomized study of laser prostatectomy and transurethral resection of the prostate in men with benign prostatic hyperplasia: 3 year follow-up. J Urol 2001; 165(Suppl 5):297.
260. Tuhkanen K, Heino A, Ala-Opas M. Hybrid laser treatment compared with transurethral resection of the prostate for symptomatic bladder outlet obstruction caused by a large benign prostate: a prospective, randomized trial with a 6-month follow-up. BJU Int 1999;84:805-9.
261. Tuhkanen K, Heino A, Ala-Opas M. Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six-month follow-up with complex urodynamic assessment. Scand J Urol Nephrol 1999; 33:31-4.
262. van Melick HH, van Venrooij GE, Eckhardt MD, Boon TA. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: urodynamic effects. J Urol 2002; 168:1058-62.
263. van Melick HH, van Venrooij GE, Eckhardt MD, Boon TA. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality. J Urol 2003;169:1411-16.
264. Hammadeh MY, Madaan S, Singh M, Philp T. Two-year follow-up of a prospective randomised trial of electrovaporization versus resection of prostate. Eur Urol 1998;34:188-92.
265. Hammadeh MY, Madaan S, Singh M, Philp T. Two years follow up of a prospective randomised trial of clectro-vaporisation of the prostate vs standard TURP. J Endourol 1998;12:S175.
266. Hammadeh MY, Fowlis GA, Singh M, Philp T. Transurethral electrovaporization of the prostate - a possible alternative to transurethral resection: a one-year follow-up of a prospective randomized trial. Br J Urol 1998;81:721-5.
267. Hammadeh MY, Madaan S, Singh M, Philp T. Three years follow up of a prospective randomised trial comparing transurethral electrovaporization of the prostate to standard TURP. J Endourol 1999;13:A29.
268. Hammadeh MY, Madaan S, Singh M, Philp T. A 3-year follow-up of a prospective randomized trial comparing transurethral electrovaporization of the prostate with standard transurethral prostatectomy. BJU Int 2000;86:648-51.
269. Hammadeh MY, Madaan S, Hines J, Philp T. The efficacy and durability of transurethral electrovaporisation of the prostate: 5 year result of a prospective randomised trial. Eur Urol Suppl 2003;2:168.
270. McAllister WJ, Karim O, Plail RO, Samra DR, Steggall MJ, Yang Q, et al. Transurethral electrovaporization of the prostate: is it any better than conventional transurethral resection of the prostate? BJU Int 2003;91:211-14.
271. Puppo P, Perachino M, Breda G, Boccafoschi C, Comeri G, Francesca F, et al. Transurethral electrovaporization of the prostate (T.V.P.): a multicentric randomized comparative study vs TURP. J Urol 1996; 155(Suppl 5):408A
272. Love CJ, Dowling C, Pham T, Tan A, McFarlane JP, Dunsmuir WD. Gyrus (R) bipolar electrovaporization versus transurethral resection of the prostate: a randomized prospective trial with 1-year follow-up. J Urol 2003;169:390.
273. Kok ET, McDonnell J, Stolk EA, Stoevelaar HJ, Busschbach JJV. The valuation of the international prostate symptom score (IPSS) for use in economic evaluations. Eur Urol 2002;42:491-7.
274. Tweedie RL, Scott DJ, Biggerstaff BJ, Mengersen KL. Bayesian meta-analysis, with application to studies of ETS and lung cancer. Lung Cancer 1996;14:S171-94.
275. Newcombe RG. Towards a reduction in publication bias. BMJ 1987; 295:656-9.
276. Thornton A, Lee P. Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 2000;53:207-16.
277. Greenland S. Quality scores are useless and potentially misleading. [Reply to "Re: A critical look at some popular analytical methods".] Am J Epidemiol 1994;140:300-1.
278. Greenland S, O'Rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchial view of proposed solutions. Biostatistics 2001;2:463-71.
279. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001; 323:42-6.
280. Soares HP, Daniels S, Kumar A, Clarke M, Scott C, Swann S, et al. Bad reporting does not mean bad methods for randomised trials: observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group. BMJ 2004;328:22-4.
281. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995; 273:408-12.
282. Schulz KF. Assessing allocation concealment and blinding in randomised controlled trials: why bother? Evid Based Nurs 2001;4:4-6.
283. Wiebe N, Vandermeer B, Platt RW, Klassen TP, Moher D, Barrowman NJ. A systematic review identifies a lack of standardization in methods for handling missing variance data. J Clin Epidemiol 2006; 59:342-53.
284. Barry MJ, Fowler FJ, Jr, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol 1992; 148:1558-63.
285. Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, et al. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess 2004;8:1-158.
286. National Institute for Clinical Excellence. Guide on the methods of technology appraisal (reference N0515). National Institut -for Clinical Excellence, 2004. URL: www.nice.org.uk/page.aspx?o=201973. Accessed September 2006.
287. Djavan B, Roehrborn CG, Shariat S, Ghawidel K, Marberger M. Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia. J Urol 1999;161:139-43.
288. Djavan B, Seitz C, Roehrborn CG, Remzi M, Fakhari M, Waldert M, et al. Targeted transurethral microwave thermotherapy versus alpha-blockade in benign prostatic hyperplasia: outcomes at 18 months. Urology 2001;57:66-70.
289. Bouchier-Hayes DM, Anderson P, Van Appledom S, Bugeja P, Costello AJ. A randomised trial comparing photoselective vaporization of the prostate (PVP) and transurethral resection of the prostate (TURP) in treatment of LUTS. J Urol 2006;175:463.